{"id":"nonoxynol","rwe":[{"pmid":"41672448","year":"2026","title":"Computational modeling and experimental validation for developed non-hormonal in-situ reversible cervical contraceptive plugs.","finding":"","journal":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","studyType":"Clinical Study"},{"pmid":"41294543","year":"2025","title":"Bioresponsive Hydrogel for On-Demand Nonhormonal Contraception.","finding":"","journal":"Gels (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"40848948","year":"2025","title":"Expansion of genital Tregs reduces neutrophil influx and maintains mucosal barrier integrity during inflammatory bacteria challenge.","finding":"","journal":"Mucosal immunology","studyType":"Clinical Study"},{"pmid":"39820483","year":"2025","title":"Regulation of reactive oxygen species and the role of mitochondrial apoptotic-related genes in rheumatoid arthritis.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"29999743","year":"2006","title":"Nonoxynol-9.","finding":"","journal":"","studyType":"Clinical Study"}],"_fda":{"id":"de962fbf-0693-4095-90ae-bd32e9835461","set_id":"34be97cd-3646-427d-8112-ba0030ff8d88","openfda":{"unii":["48Q180SH9T"],"route":["VAGINAL"],"rxcui":["198765","1597814"],"spl_id":["de962fbf-0693-4095-90ae-bd32e9835461"],"brand_name":["VCF CONTRACEPTIVE PRE-FILLED APPLICATORS"],"spl_set_id":["34be97cd-3646-427d-8112-ba0030ff8d88"],"package_ndc":["52925-512-10","52925-512-25"],"product_ndc":["52925-512"],"generic_name":["NONOXYNOL-9"],"product_type":["HUMAN OTC DRUG"],"substance_name":["NONOXYNOL-9"],"manufacturer_name":["APOTHECUS PHARMACEUTICAL CORP"],"application_number":["505G(a)(3)"],"is_original_packager":[true]},"purpose":["Purpose Vaginal Contraceptive"],"version":"7","stop_use":["Stop use and ask a doctor if you or your partner get burning, itching, a rash, or other irritation of the vagina or penis."],"warnings":["Warnings For Vaginal Use Only Not for rectal (anal) use. Sexually Transmitted Disease (STDs) alert This product does not protect against HIV (AIDS) or other STDs and may increase the risk of getting HIV from an infected partner. Do not use if you or your sex partner has HIV/AIDS. If you do not know if you or your sex partner is infected, choose another form of birth control Stop use and ask a doctor if you or your partner get burning, itching, a rash, or other irritation of the vagina or penis. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away."],"questions":["Questions? If you have any questions, call our toll-free line at 1-800-879-2393 between 9:00AM and 5:00PM EST, Monday through Friday."],"do_not_use":["Do not use if you or your sex partner has HIV/AIDS. If you do not know if you or your sex partner is infected, choose another form of birth control"],"effective_time":"20251212","active_ingredient":["Active Ingredient Nonoxynol-9, (4%)"],"inactive_ingredient":["Inactive Ingredients purified water, propylene glycol, CMC 7MF, sorbitol solution, PVP K 30, simethicone, lactic acid, methyl paraben, potassium sorbate, sodium benzoate, trisodium EDTA"],"storage_and_handling":["Other Information When used correctly every time you have sex, latex condoms greatly reduce, but do not eliminate, the risk of catching or spreading HIV, the virus that causes AIDS. Use a latex condom without nonoxynol-9 if you or your sex partner has HIV/AIDS, multiple sex partners, or other HIV risk factors. VCF ® is tested by independent laboratories for determination of sperm inactivating qualities, using the I.P.P.F. agreed protocol Store at room temperature, 59° - 86° F (15° - 30° C). Avoid exposure to extremes of hot and cold."],"indications_and_usage":["Use for the prevention of pregnancy with condom or alone"],"spl_unclassified_section":["Drug Facts","Distributed By: Apothecus Pharmaceutical Corp. Oyster Bay, NY 11771"],"dosage_and_administration":["Directions For maximum protection against unwanted pregnancy, follow the enclosed directions exactly. Insert one applicatorful into the vagina prior to intercourse (see complete, illustrated directions on package insert). Each applicatorful is effective immediately and up to one hour after application. An additional applicatorful is required prior to each act of intercourse, regardless of time since last application."],"spl_product_data_elements":["VCF CONTRACEPTIVE PRE-FILLED APPLICATORS NONOXYNOL-9 NONOXYNOL-9 NONOXYNOL-9 Water Propylene Glycol Sodium Benzoate Sorbitol Povidone K30 Lactic Acid, Unspecified Form Methylparaben Potassium Sorbate Edetate Trisodium"],"keep_out_of_reach_of_children":["Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 2.55 g Applicator Box New! Compare To CONCEPTROL ® ! VCF ® Vaginal Contraceptive Gel FOR PREVENTION OF PREGNANCY Pre-Filled Applicators Safe and effective Hormone free Easy to use Contains the Spermicide Doctors Recommend Most 10 PRE-FILLED APPLICATORS NET WT. 0.09 oz. (2.55g) EACH PRINCIPAL DISPLAY PANEL - 2.55 g Applicator Box"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Vaginal","category":"route"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"prevention of pregnancy","category":"indication"},{"label":"Mayer Labs Inc","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DYSURIA","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"BURNING SENSATION","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"DYSPAREUNIA","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"VAGINAL HAEMORRHAGE","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"VULVOVAGINAL DISCOMFORT","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"VULVOVAGINAL PAIN","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"VULVOVAGINAL SWELLING","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"CHEMICAL BURN OF GENITALIA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"1 reports"}]},"trials":[],"aliases":[],"company":"Mayer Labs Inc","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=NONOXYNOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:23:15.358676+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:23:22.051783+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NONOXYNOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:23:22.870656+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:23:13.124870+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:23:13.124917+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:23:24.398524+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108472/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:23:23.400698+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"505G(a)(3)","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:23:13.124922+00:00"}},"allNames":"vcf contraceptive pre-filled applicators","offLabel":[],"synonyms":["Vcf Contraceptive Pre-Filled Applicators","NONOXYNOL-9"],"timeline":[{"date":"1983-04-01","type":"positive","source":"FDA Orange Book","milestone":"Today approved — 1GM"},{"date":"2000-01-01","type":"neutral","source":"FDA Orange Book","milestone":"Rights transferred from Apothecus Pharmaceutical Corp to Mayer Labs Inc"}],"approvals":[],"brandName":"Vcf Contraceptive Pre-Filled Applicators","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Nonoxynol, the active ingredient in Vcf Contraceptive Pre-Filled Applicators, is a nonionic surfactant that disrupts the cell membrane of sperm, ultimately leading to their death."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"NONOXYNOL\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=nonoxynol","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=nonoxynol","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-31T10:38:11.899937","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:23:26.287427+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"nonoxynol","indications":{"approved":[{"name":"prevention of pregnancy","source":"OpenFDA Label","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"currentOwner":"Mayer Labs Inc","drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[{"nctId":"NCT07203885","phase":"NA","title":"AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment","status":"COMPLETED","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2025-09-09","conditions":["Acute Promyelocytic Leukemia (APL)","Acute Myeloid Leukaemia (AML)"],"enrollment":10,"completionDate":"2025-10-10"},{"nctId":"NCT03115710","phase":"","title":"The K-Map Study, Global Prevalence of KC","status":"RECRUITING","sponsor":"University Hospital, Geneva","startDate":"2015-12-28","conditions":["Keratoconus"],"enrollment":20000,"completionDate":"2030-02-01"},{"nctId":"NCT06484010","phase":"NA","title":"Effectiveness of SNAPPS in Family Medicine Residency Program","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2023-03-15","conditions":["Medical Education"],"enrollment":36,"completionDate":"2023-08-30"},{"nctId":"NCT03924440","phase":"","title":"Ovulation Double Check (Proov) Verification and Usability Testing","status":"COMPLETED","sponsor":"MFB Fertility","startDate":"2016-10-01","conditions":["Ovulation Disorder"],"enrollment":100,"completionDate":"2022-12-31"},{"nctId":"NCT06203080","phase":"PHASE2","title":"The Contraceptive Efficacy and Safety of an Intravaginal Acetic Acid Thermoreversible Gel on Chinese Women.","status":"NOT_YET_RECRUITING","sponsor":"National Research Institute for Family Planning, China","startDate":"2024-01-01","conditions":["Contraceptive Device; Complications"],"enrollment":240,"completionDate":"2026-06-30"},{"nctId":"NCT01306331","phase":"PHASE3","title":"Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel","status":"COMPLETED","sponsor":"Evofem Inc.","startDate":"2011-04","conditions":["Contraception"],"enrollment":3389,"completionDate":"2014-06"},{"nctId":"NCT05250882","phase":"NA","title":"Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage","status":"UNKNOWN","sponsor":"Amsterdam UMC, location VUmc","startDate":"2021-09-05","conditions":["Anastomotic Leak Small Intestine","Anastomotic Leak Large Intestine","Anastomotic Leak Rectum","Intraoperative Awareness"],"enrollment":1600,"completionDate":"2023-12-01"},{"nctId":"NCT00000926","phase":"PHASE3","title":"A Study of Nonoxynol-9 (N-9) and HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":["HIV Infections"],"enrollment":4400,"completionDate":"2001-02"},{"nctId":"NCT00000929","phase":"PHASE1","title":"A Study of the Effects of Advantage 24 on the Rectum","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":["HIV Infections"],"enrollment":70,"completionDate":"1999-07"},{"nctId":"NCT01262053","phase":"NA","title":"Investigating Wrong-Patient Computerized Physician Order Entry (CPOE) Errors","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2010-12","conditions":["Wrong Patient Computerized Physician Order Entry Errors"],"enrollment":4028,"completionDate":"2011-06"},{"nctId":"NCT00274261","phase":"PHASE3","title":"Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®","status":"COMPLETED","sponsor":"Premier Research","startDate":"2004-06","conditions":["Pregnancy"],"enrollment":1565,"completionDate":"2008-09"},{"nctId":"NCT00578877","phase":"PHASE2,PHASE3","title":"Contraceptive Effectiveness and Safety of the SILCS Diaphragm","status":"COMPLETED","sponsor":"CONRAD","startDate":"2008-01","conditions":["Contraception"],"enrollment":450,"completionDate":"2009-11"},{"nctId":"NCT02545452","phase":"PHASE1","title":"Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-09-15","conditions":["Endometriosis"],"enrollment":52,"completionDate":"2016-07-29"},{"nctId":"NCT00065858","phase":"PHASE2,PHASE3","title":"Effectiveness of BufferGel as a Vaginal Contraceptive","status":"COMPLETED","sponsor":"Premier Research","startDate":"2001-09","conditions":["Pregnancy"],"enrollment":975,"completionDate":"2005-04"},{"nctId":"NCT02309554","phase":"PHASE1","title":"Postcoital Testing Study of the SILCS Diaphragm Used With 3% N-9 Gel, ContraGel, or No Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2014-12","conditions":["Contraception"],"enrollment":27,"completionDate":"2016-03"},{"nctId":"NCT02168452","phase":"","title":"Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2014-06","conditions":["Breast Cancer"],"enrollment":5,"completionDate":"2015-01"},{"nctId":"NCT01200303","phase":"PHASE2,PHASE3","title":"Evaluation of Computer-assisted, Non-cathartic CT Colonography","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2005-06","conditions":["Colonic Polyps"],"enrollment":605,"completionDate":"2011-01"},{"nctId":"NCT00389311","phase":"EARLY_PHASE1","title":"A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2007-04","conditions":["HIV Infections"],"enrollment":12,"completionDate":"2009-06"},{"nctId":"NCT01593124","phase":"PHASE2","title":"Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-05","conditions":["Vaginal Inflammation","Vaginal Infections"],"enrollment":20,"completionDate":"2013-04"},{"nctId":"NCT00692952","phase":"PHASE2","title":"Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial","status":"COMPLETED","sponsor":"Shanghai Institute of Planned Parenthood Research","startDate":"2004-03","conditions":["Healthy"],"enrollment":240,"completionDate":"2005-11"},{"nctId":"NCT00561613","phase":"PHASE1","title":"Postcoital Testing of the SILCS Diaphragm","status":"COMPLETED","sponsor":"CONRAD","startDate":"2003-08","conditions":["Contraceptive Device"],"enrollment":40,"completionDate":"2004-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Vaginal"},"_patentsChecked":true,"crossReferences":{"UNII":"48Q180SH9T","RXCUI":"198765,1597814","SPL_ID":"de962fbf-0693-4095-90ae-bd32e9835461","chemblId":"CHEMBL2108472"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Apothecus Pharmaceutical Corp","relationship":"Original Developer"},{"period":"present","companyName":"Mayer Labs Inc","relationship":"Current Owner"}],"publicationCount":712,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Apothecus Pharmaceutical Corp","recentPublications":[{"date":"2026 Feb 11","pmid":"41672448","title":"Computational modeling and experimental validation for developed non-hormonal in-situ reversible cervical contraceptive plugs.","journal":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception"},{"date":"2025 Oct 27","pmid":"41294543","title":"Bioresponsive Hydrogel for On-Demand Nonhormonal Contraception.","journal":"Gels (Basel, Switzerland)"},{"date":"2025 Dec","pmid":"40848948","title":"Expansion of genital Tregs reduces neutrophil influx and maintains mucosal barrier integrity during inflammatory bacteria challenge.","journal":"Mucosal immunology"},{"date":"2025 Jan 16","pmid":"39820483","title":"Regulation of reactive oxygen species and the role of mitochondrial apoptotic-related genes in rheumatoid arthritis.","journal":"Scientific reports"},{"date":"2006","pmid":"29999743","title":"Nonoxynol-9.","journal":""}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"active","companyName":"Mayer Labs Inc","companyId":"mayer-labs-inc","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":2,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:23:26.287427+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}